Progyny, Inc. Increase (Decrease) in Accounts Receivable
Progyny, Inc. (PGNY) reported Increase (Decrease) in Accounts Receivable of $47.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-07
- Progyny, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$385.00K.
- Progyny, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $47.77M, a 31.49% decline year-over-year.
- Progyny, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$27.04M.
- Progyny, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$15.01M.
- Progyny, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $5.12M, a 48.18% decline from fiscal 2024.
- Progyny, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $9.87M, a 54.58% decline from fiscal 2023.
- Progyny, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $21.74M, a 81.78% decline from fiscal 2022.
- Progyny, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $119.30M, a 73.72% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$385.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $47.39M 10-Q · filed 2026-08-07 | $20.35M derived: sum of 3 quarters · filed 2026-08-07 | $5.34M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $47.77M 10-Q · filed 2026-05-08 | $20.73M derived: sum of 2 quarters · filed 2026-05-08 | $5.72M derived: sum of 3 quarters · filed 2026-05-08 | -$16.84M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$27.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$42.05M derived: sum of 2 quarters · filed 2026-02-27 | -$64.61M derived: sum of 3 quarters · filed 2026-08-07 | $5.12M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$15.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$37.58M derived: sum of 2 quarters · filed 2026-08-07 | $32.16M 10-Q · filed 2025-11-07 | -$9.55M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$22.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $47.17M 10-Q · filed 2026-08-07 | $5.46M derived: sum of 3 quarters · filed 2026-08-07 | -$4.46M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $69.73M 10-Q · filed 2026-05-08 | $28.03M derived: sum of 2 quarters · filed 2026-05-08 | $18.11M derived: sum of 3 quarters · filed 2026-05-08 | $19.49M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$41.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$51.62M derived: sum of 2 quarters · filed 2026-02-27 | -$50.24M derived: sum of 3 quarters · filed 2026-02-27 | $9.87M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$9.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$8.54M derived: sum of 2 quarters · filed 2025-11-07 | $51.58M 10-Q · filed 2025-11-07 | $29.56M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $61.50M 10-Q · filed 2025-08-08 | $39.47M derived: sum of 3 quarters · filed 2026-02-27 | $48.55M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $60.12M 10-Q · filed 2025-05-09 | $38.09M derived: sum of 2 quarters · filed 2026-02-27 | $47.17M derived: sum of 3 quarters · filed 2026-02-27 | $3.43M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$22.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$12.95M derived: sum of 2 quarters · filed 2026-02-27 | -$56.68M derived: sum of 3 quarters · filed 2026-02-27 | $21.74M 10-K · filed 2026-02-27 |
| 2023-09-30 | $9.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$34.66M derived: sum of 2 quarters · filed 2024-11-12 | $43.76M 10-Q · filed 2024-11-12 | $29.90M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$43.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $34.69M 10-Q · filed 2024-08-07 | $20.83M derived: sum of 3 quarters · filed 2025-03-03 | $52.59M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $78.42M 10-Q · filed 2024-05-10 | $64.56M derived: sum of 2 quarters · filed 2025-03-03 | $96.32M derived: sum of 3 quarters · filed 2025-03-03 | $131.88M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$13.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $17.90M derived: sum of 2 quarters · filed 2025-03-03 | $53.46M derived: sum of 3 quarters · filed 2025-03-03 | $119.30M 10-K · filed 2025-03-03 |
| 2022-09-30 | $31.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $67.32M derived: sum of 2 quarters · filed 2023-11-08 | $133.16M 10-Q · filed 2023-11-08 | $135.10M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $35.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $101.41M 10-Q · filed 2023-08-04 | $103.34M derived: sum of 3 quarters · filed 2024-02-29 | $100.17M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $65.84M 10-Q · filed 2023-05-09 | $67.78M derived: sum of 2 quarters · filed 2024-02-29 | $64.61M derived: sum of 3 quarters · filed 2024-02-29 | $91.00M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$1.23M derived: sum of 2 quarters · filed 2024-02-29 | $25.16M derived: sum of 3 quarters · filed 2024-02-29 | $68.68M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$3.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $23.22M derived: sum of 2 quarters · filed 2022-11-04 | $66.74M 10-Q · filed 2022-11-04 | $67.12M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $26.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $69.91M 10-Q · filed 2022-08-05 | $70.29M derived: sum of 3 quarters · filed 2023-03-01 | $84.84M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $43.52M 10-Q · filed 2022-05-06 | $43.90M derived: sum of 2 quarters · filed 2023-03-01 | $58.46M derived: sum of 3 quarters · filed 2023-03-01 | $58.80M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $384.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $14.94M derived: sum of 2 quarters · filed 2023-03-01 | $15.28M derived: sum of 3 quarters · filed 2023-03-01 | $35.34M 10-K · filed 2023-03-01 |
| 2020-09-30 | $14.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $14.90M derived: sum of 2 quarters · filed 2021-11-08 | $34.95M 10-Q · filed 2021-11-08 | $37.95M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $346.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $20.40M 10-Q · filed 2021-08-06 | $23.40M derived: sum of 3 quarters · filed 2022-03-01 | $23.72M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $20.05M 10-Q · filed 2021-05-07 | $23.05M derived: sum of 2 quarters · filed 2022-03-01 | $23.38M derived: sum of 3 quarters · filed 2022-03-01 | $28.80M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.32M derived: sum of 2 quarters · filed 2022-03-01 | $8.75M derived: sum of 3 quarters · filed 2022-03-01 | $25.34M 10-K · filed 2022-03-01 |
| 2019-09-30 | $326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $5.75M derived: sum of 2 quarters · filed 2020-11-06 | $22.34M 10-Q · filed 2020-11-06 | $19.78M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $5.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $22.02M 10-Q · filed 2020-08-07 | $19.45M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $16.60M 10-Q · filed 2020-05-14 | $14.03M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | -$2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $12.78M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $15.34M 10-Q · filed 2019-12-06 | |||
| 2017-12-31 | $2.04M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |